[{"address1": "919 East Hillsdale Boulevard", "address2": "Suite 250", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 473 7700", "website": "https://www.geron.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.", "fullTimeEmployees": 141, "companyOfficers": [{"maxAge": 1, "name": "Dr. John A. Scarlett M.D.", "age": 72, "title": "Chairman of the Board, President & CEO", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 1361092, "exercisedValue": 0, "unexercisedValue": 2818152}, {"maxAge": 1, "name": "Ms. Michelle J. Robertson", "age": 56, "title": "Executive VP, CFO, Treasurer and Principal Financial & Accounting Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 340979, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew J. Grethlein Ph.D.", "age": 59, "title": "Executive VP & COO", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 827011, "exercisedValue": 0, "unexercisedValue": 941614}, {"maxAge": 1, "name": "Mr. Scott  Samuels", "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "fiscalYear": 2023, "totalPay": 485317, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Aron  Feingold", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shannon  Odam", "age": 48, "title": "Senior VP & Chief People Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa A. Kelly Behrs", "age": 59, "title": "Executive VP of Business Operations & Chief Alliance Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 753220, "exercisedValue": 0, "unexercisedValue": 41563}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 6, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.29, "open": 4.27, "dayLow": 4.23, "dayHigh": 4.34, "regularMarketPreviousClose": 4.29, "regularMarketOpen": 4.27, "regularMarketDayLow": 4.23, "regularMarketDayHigh": 4.34, "beta": 0.505, "forwardPE": -23.777779, "volume": 4440085, "regularMarketVolume": 4440085, "averageVolume": 11959035, "averageVolume10days": 7678060, "averageDailyVolume10Day": 7678060, "bid": 4.27, "ask": 4.33, "bidSize": 1600, "askSize": 500, "marketCap": 2579967232, "fiftyTwoWeekLow": 1.64, "fiftyTwoWeekHigh": 5.34, "priceToSalesTrailing12Months": 1879.073, "fiftyDayAverage": 4.564, "twoHundredDayAverage": 3.27015, "currency": "USD", "enterpriseValue": 2310300928, "floatShares": 555879984, "sharesOutstanding": 602796032, "sharesShort": 69108061, "sharesShortPriorMonth": 44657819, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.1146, "heldPercentInsiders": 0.00086000003, "heldPercentInstitutions": 0.78073, "shortRatio": 6.52, "shortPercentOfFloat": 0.1153, "bookValue": 0.51, "priceToBook": 8.392158, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -219551008, "trailingEps": -0.35, "forwardEps": -0.18, "pegRatio": -2.61, "lastSplitFactor": "1058:1000", "lastSplitDate": 1405987200, "enterpriseToRevenue": 1682.666, "enterpriseToEbitda": -10.188, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "GERN", "underlyingSymbol": "GERN", "shortName": "Geron Corporation", "longName": "Geron Corporation", "firstTradeDateEpochUtc": 838819800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c31a9eb1-93e6-345d-be75-d9dfbe5121ea", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.28, "targetHighPrice": 10.0, "targetLowPrice": 5.5, "targetMeanPrice": 7.36, "targetMedianPrice": 7.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 362734016, "totalCashPerShare": 0.602, "ebitda": -226772992, "totalDebt": 87042000, "quickRatio": 3.534, "currentRatio": 3.605, "totalRevenue": 1373000, "debtToEquity": 28.381, "revenuePerShare": 0.002, "returnOnAssets": -0.32868, "returnOnEquity": -0.72564006, "freeCashflow": -126945872, "operatingCashflow": -207508000, "revenueGrowth": 29.414, "operatingMargins": -78.60884, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]